Skip to main content
SpringerLink
Log in

Interaction rein et cœur

  • Chapter
Book cover L’insuffisance rénale aiguë

Part of the book series: Le point sur … ((POINT))

  • 564 Accesses

Abstrait

Au cours des dix dernières années, la compréhension de la physiologie rénale et cardiaque n’a cessé de s’affiner, mettant en lumière l’importance de leurs interactions, tant hémodynamiques, neurogéniques qu’hormonales, et ce aussi bien chez le sujet normal qu’en pathologie. Si les maladies cardiovasculaires sont connues pour retentir sur le rein et se compliquer potentiellement d’insuffisance rénale, à l’inverse le rôle du rein dans la genèse de pathologies cardiaques est souvent négligé. Nous aborderons donc successivement les différents aspects de ces interactions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Lameire N, Van Biesen W, Vanholder R (2005) Acute renal failure. Lancet 365: 417–30

    PubMed  CAS  Google Scholar 

  2. Canaud B, Leblanc M, Leray-Moragues H (1998) Slow continuous and daily ultrafiltration for refractory congestive heart failure. Nephrol Dial Transplant 13Suppl 4: 51–5

    Article  PubMed  Google Scholar 

  3. Canaud B, Andrianatony M, Amigues L, Leray-Moragues H (2001) Hémofiltration: un complément thérapeutique logique au traitement de l’ICC. Cardioscopies 86: 61–7

    Google Scholar 

  4. Hillege HL, Girbes AR, de Kam PJ et al. (2000) Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 102: 203–10

    PubMed  CAS  Google Scholar 

  5. Brosius FC, 3rd, Hostetter TH, Kelepouris E et al. (2006) Detection of Chronic Kidney Disease in Patients With or at Increased Risk of Cardiovascular Disease. A Science Advisory From the American Heart Association Kidney and Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group Developed in Collaboration With the National Kidney Foundation. Circulation 114(10): 1083–7

    Article  PubMed  CAS  Google Scholar 

  6. Delles C, Schmieder RE (2001) The kidney in congestive heart failure: renal adverse event rate of treatment. J Cardiovasc Pharmacol 38: 99–107

    Article  PubMed  CAS  Google Scholar 

  7. Schwartz D, Kornowski R, Schwartz IF et al. (1996) Prediction of renal impairment in elderly patients with congestive heart failure treated with captopril. Cardiovasc Drugs Ther 10: 75–9.

    PubMed  CAS  Google Scholar 

  8. Effects of enalapril on mortality in severe congestive heart failure (1987). Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med 316: 1429–35.

    Google Scholar 

  9. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure (1993). The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Lancet 342: 821–8

    Google Scholar 

  10. Cohn JN, Johnson G, Ziesche S et al. (1991) A comparison of enalapril with hydralazineisosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 325: 303–10

    Article  PubMed  CAS  Google Scholar 

  11. Pitt B, Segal R, Martinez FA et al. (1997) Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet 349: 747–52

    Article  PubMed  CAS  Google Scholar 

  12. Davies MK, Gibbs CR, Lip GY (2000). ABC of heart failure. Management: diuretics, ACE inhibitors, and nitrates. BMJ 320: 428–31

    Article  PubMed  CAS  Google Scholar 

  13. Gomberg-Maitland M, Baran DA, Fuster V (2001) Treatment of congestive heart failure: guidelines for the primary care physician and the heart failure specialist. Arch Intern Med 161: 342–52

    Article  PubMed  CAS  Google Scholar 

  14. Pitt B, Zannad F, Remme WJ et al. (1999) The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341: 709–17

    Article  PubMed  CAS  Google Scholar 

  15. Farquharson CA, Struthers AD (2000) Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I/angiotensin II conversion in patients with chronic heart failure. Circulation 101: 594–7

    PubMed  CAS  Google Scholar 

  16. Marenzi G, Guazzi M, Lauri G et al. (1994) Body fluid withdrawal with isolated ultrafiltration effects persistent improvement of functional capacity in patients with chronic congestive heart failure. Furosemide does not produce the same result. Cardiologia 39: 763–72

    PubMed  CAS  Google Scholar 

  17. Marenzi G, Lauri G, Grazi M et al. (2001) Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J Am Coll Cardiol 2001; 38: 963–8

    Article  PubMed  CAS  Google Scholar 

  18. Rimondini A, Cipolla CM, Della Bella P et al. (1987) Hemofiltration as short-term treatment for refractory congestive heart failure. Am J Med 83: 43–8

    Article  PubMed  CAS  Google Scholar 

  19. Marenzi GC, Lauri G, Guazzi M, Perego GB, Agostoni PG (1995) Ultrafiltration in moderate heart failure. Exercise oxygen uptake as a predictor of the clinical benefits. Chest 108: 94–8

    PubMed  CAS  Google Scholar 

  20. Dormans TP, Huige RM, Gerlag PG (1996) Chronic intermittent haemofiltration and haemodialysis in end stage chronic heart failure with oedema refractory to high dose frusemide. Heart 75: 349–51

    Article  PubMed  CAS  Google Scholar 

  21. Swedberg K, Cleland J, Dargie H et al. (2005) Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26: 1115–40

    Article  PubMed  CAS  Google Scholar 

  22. Ohta Y, Tsuchihashi T, Ohya Y et al. (2001) Trends in the pathophysiological characteristics of malignant hypertension. Hypertens Res 24: 489–92

    Article  PubMed  CAS  Google Scholar 

  23. van den Born BJ, Honnebier UP, Koopmans RP, van Montfrans GA (2005) Microangiopathic hemolysis and renal failure in malignant hypertension. Hypertension 45: 246–51

    Article  PubMed  CAS  Google Scholar 

  24. Kitiyakara C, Guzman NJ (1998) Malignant hypertension and hypertensive emergencies. J Am Soc Nephrol 9: 133–42

    PubMed  CAS  Google Scholar 

  25. Rosner M, Okusa M (2006) Acute kidney injury associated with cardiac surgery. Clin J Am Soc Nephrol 1: 19–32

    Article  PubMed  Google Scholar 

  26. Mehta RL (2005) Acute renal failure and cardiac surgery: marching in place or moving ahead? J Am Soc Nephrol 16: 12–4

    Article  PubMed  Google Scholar 

  27. Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J (1998) Independent association between acute renal failure and mortality following cardiac surgery. Am J Med 104: 343–8

    Article  PubMed  CAS  Google Scholar 

  28. Thakar CV, Worley S, Arrigain S, Yared JP, Paganini EP (2005) Influence of renal dysfunction on mortality after cardiac surgery: modifying effect of preoperative renal function. Kidney Int 67: 1112–9

    Article  PubMed  Google Scholar 

  29. Chertow GM, Lazarus JM, Christiansen CL et al. (1997) Preoperative renal risk stratification. Circulation 95: 878–84

    PubMed  CAS  Google Scholar 

  30. Loef BG, Epema AH, Smilde TD et al. (2005) Immediate postoperative renal function deterioration in cardiac surgical patients predicts in-hospital mortality and long-term survival. J Am Soc Nephrol 16: 195–200

    Article  PubMed  Google Scholar 

  31. Gupta R, Gurm H, Bhatt D, Chew D, Ellis S (2005) Renal failure after percutaneous coronary intervention is associated with high mortality. Catheter Cardiovasc Interv 64: 442–8

    Article  PubMed  Google Scholar 

  32. Mangano CM, Diamondstone LS, Ramsay JG et al. (1998) Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med 128: 194–203

    PubMed  CAS  Google Scholar 

  33. Bucerius J, Gummert JF, Walther T et al. (2004) On-pump versus off-pump coronary artery bypass grafting: impact on postoperative renal failure requiring renal replacement therapy. Ann Thorac Surg 77: 1250–6

    Article  PubMed  Google Scholar 

  34. Schwann NM, Horrow JC, Strong MD, 3rd et al. (2004) Does off-pump coronary artery bypass reduce the incidence of clinically evident renal dysfunction after multivessel myocardial revascularization? Anesth Analg 99: 959–64

    Article  PubMed  Google Scholar 

  35. Chukwuemeka A, Weisel A, Maganti M et al. (2005) Renal dysfunction in high-risk patients after on-pump and off-pump coronary artery bypass surgery: a propensity score analysis. Ann Thorac Surg 80: 2148–53

    Article  PubMed  Google Scholar 

  36. Asimakopoulos G, Karagounis AP, Valencia O et al. (2005) Renal function after cardiac surgery off-versus on-pump coronary artery bypass: analysis using the Cockroft-Gault formula for estimating creatinine clearance. Ann Thorac Surg 79: 2024–31

    Article  PubMed  Google Scholar 

  37. Mangano DT, Tudor IC, Dietzel C (2006) The risk associated with aprotinin in cardiac surgery. N Engl J Med 354: 353–65

    Article  PubMed  CAS  Google Scholar 

  38. Porte RJ, Leebeek FW (2002) Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery. Drugs 62: 2193–211

    Article  PubMed  CAS  Google Scholar 

  39. Horl WH (2000) Aprotinin and renal function in patients undergoing cardiac surgery. Br J Anaesth 84: 3–5.

    PubMed  CAS  Google Scholar 

  40. Conférence de consensus en réanimation et médecine d’urgence (1998) Épuration extrarénale continue en réanimation. Réan Urg 7: 183–8

    Google Scholar 

  41. Kamel KS, Wei C (2003) Controversial issues in the treatment of hyperkalaemia. Nephrol Dial Transplant 18: 2215–8

    Article  PubMed  Google Scholar 

  42. Mahoney BA, Smith WA, Lo DS et al. (2005) Emergency interventions for hyperkalaemia. Cochrane Database Syst Rev CD003235

    Google Scholar 

  43. Allon M, Shanklin N (1996) Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol. Am J Kidney Dis 28: 508–14

    PubMed  CAS  Google Scholar 

  44. Zakynthinos E, Theodorakopoulou M, Daniil Z, Konstantinidis K, Zakynthinos S (2004) Hemorrhagic cardiac tamponade in critically ill patients with acute renal failure. Heart Lung 33: 55–60.

    Article  PubMed  Google Scholar 

  45. K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease (2003) Am J Kidney Dis 41: I-IV: S1–91

    Google Scholar 

  46. Barrett N, Spencer S, McIvor J, Brown EA (1988) Subclavian stenosis: a major complication of subclavian dialysis catheters. Nephrol Dial Transplant 3: 423–5

    PubMed  CAS  Google Scholar 

  47. Cimochowski GE, Worley E, Rutherford WE et al. (1990) Superiority of the internal jugular over the subclavian access for temporary dialysis. Nephron 54: 154–61

    Article  PubMed  CAS  Google Scholar 

  48. Schillinger F, Schillinger D, Montagnac R, Milcent T (1991) Post catheterisation vein stenosis in haemodialysis: comparative angiographic study of 50 subclavian and 50 internal jugular accesses. Nephrol Dial Transplant 6: 722–4

    PubMed  CAS  Google Scholar 

  49. Ronco C, Bellomo R, Homel P et al. (2000) Effects of different doses in continuous venovenous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 356: 26–30

    Article  PubMed  CAS  Google Scholar 

  50. Cole L, Bellomo R, Journois D et al. (2001) High-volume haemofiltration in human septic shock. Intensive Care Med 27: 978–86

    Article  PubMed  CAS  Google Scholar 

  51. Honore PM, Jamez J, Wauthier M et al. (2000) Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 28: 3581–7

    Article  PubMed  CAS  Google Scholar 

  52. Joannes-Boyau O, Rapaport S, Bazin R, Fleureau C, Janvier G (2004) Impact of high volume hemofiltration on hemodynamic disturbance and outcome during septic shock. Asaio J 50: 102–9

    Article  PubMed  Google Scholar 

  53. Piccinni P, Dan M, Barbacini S et al. (2006) Early isovolaemic haemofiltration in oliguric patients with septic shock. Intensive Care Med 32: 80–6

    Article  PubMed  CAS  Google Scholar 

  54. Wallet F, Mohammedi I, Argaud L, Martin O, Robert D (2004) Diuretics use in the intensive care unit: results of a prevalence study. Ann Fr Anesth Reanim 23: 161–2

    Article  PubMed  CAS  Google Scholar 

  55. Gupta S, Neyses L (2005) Diuretic usage in heart failure: a continuing conundrum in 2005. Eur Heart J 26: 644–9

    Article  PubMed  CAS  Google Scholar 

  56. Dikshit K, Vyden JK, Forrester JS et al. (1973) Renal and extrarenal hemodynamic effects of furosemide in congestive heart failure after acute myocardial infarction. N Engl J Med 288: 1087–90

    Article  PubMed  CAS  Google Scholar 

  57. Brater DC (1998) Diuretic therapy. N Engl J Med 339: 387–95

    Article  PubMed  CAS  Google Scholar 

  58. Dormans TP, van Meyel JJ, Gerlag PG et al. (1996) Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. J Am Coll Cardiol 28: 376–82

    Article  PubMed  CAS  Google Scholar 

  59. Aaser E, Gullestad L, Tollofsrud S et al. (1997) Effect of bolus injection versus continuous infusion of furosemide on diuresis and neurohormonal activation in patients with severe congestive heart failure. Scand J Clin Lab Invest 57: 361–7

    Article  PubMed  CAS  Google Scholar 

  60. Brezis M, Rosen S (1995) Hypoxia of the renal medulla-its implications for disease. N Engl J Med 332: 647–55

    Article  PubMed  CAS  Google Scholar 

  61. Gerlach AT, Pickworth KK (2000) Contrast medium-induced nephrotoxicity: pathophysiology and prevention. Pharmacotherapy 20: 540–8

    Article  PubMed  CAS  Google Scholar 

  62. Better OS, Stein JH (1990) Early management of shock and prophylaxis of acute renal failure in traumatic rhabdomyolysis. N Engl J Med 322: 825–9

    Article  PubMed  CAS  Google Scholar 

  63. Brown CB, Ogg CS, Cameron JS (1981) High dose frusemide in acute renal failure: a controlled trial. Clin Nephrol 15: 90–6

    PubMed  CAS  Google Scholar 

  64. Shilliday IR, Quinn KJ, Allison ME (1997) Loop diuretics in the management of acute renal failure: a prospective, double-blind, placebo-controlled, randomized study. Nephrol Dial Transplant 12: 2592–6

    Article  PubMed  CAS  Google Scholar 

  65. Anderson RJ, Linas SL, Berns AS et al. (1977) Nonoliguric acute renal failure. N Engl J Med 296: 1134–8

    Article  PubMed  CAS  Google Scholar 

  66. Wilcox CS (1999) Metabolic and adverse effects of diuretics. Semin Nephrol 19: 557–68

    PubMed  CAS  Google Scholar 

  67. Mehta RL, McDonald B, Gabbai F et al. (2002) Nephrology consultation in acute renal failure: does timing matter? Am J Med 113: 456–61

    Article  PubMed  Google Scholar 

  68. Uchino S, Doig GS, Bellomo R et al. (2004) Diuretics and mortality in acute renal failure. Crit Care Med 32: 1669–77

    Article  PubMed  Google Scholar 

  69. Anijeet H, Ganugapenta M, Fenwick S, Prasad B (2005) Loop diuretics for treating acute renal failure in adults (protocol). The Cochrane Database of systematic Reviews 1: Art.No.: CD005132.DOI: 10.1002/14651858.CD005132

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Département d’anesthésie-réanimation, Hôpital européen George-Pompidou, 20, rue Leblanc, 75015, Paris

    Anne Godier & Didier Journois

Authors
  1. Anne Godier
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Didier Journois
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Département d’anesthésie-réanimation, Hôpital Saint-louis, 1, avenue Claude Vellefaux, 75010, Paris

    Laurent Jacob

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag France

About this chapter

Cite this chapter

Godier, A., Journois, D. (2007). Interaction rein et cœur. In: Jacob, L. (eds) L’insuffisance rénale aiguë. Le point sur …. Springer, Paris. https://doi.org/10.1007/978-2-287-71152-7_9

Download citation

  • DOI: https://doi.org/10.1007/978-2-287-71152-7_9

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-287-71151-0

  • Online ISBN: 978-2-287-71152-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation